Documentos de Munoz E.G.C. | REDI

Regresar

Mostrando 2 resultados de: 2

Filtros aplicados

Origen: "google"

Subtipo de publicación

Publisher

Cardiovascular Diabetology(1)

The Lancet Diabetes and Endocrinology(1)

Área temáticas

Enfermedades(1)

Farmacología y terapéutica(1)

Fisiología humana(1)

Medicina forense; incidencia de enfermedades(1)

Área de conocimiento

Medicina interna(1)

Año de Publicación

Origen

Palabras Claves

Cardiovascular disease(1)

Glucagon like peptide-1 receptor agonists(1)

Type 2 Diabetes(1)

The effect of dulaglutide on stroke: an exploratory analysis of the REWIND trial

Abstract: Background: Cardiovascular outcome trials have suggested that glucagon-like peptide 1 (GLP-1) recept

Palabras claves:

Atisso C.M., Avezum A.J., Basile J.N., Botros F.T., Colhoun H.M., Conget I., Cushman W.C., DIaz R., Dyal L., Gerstein H.C., Hall S., Hâncu N., Hanefeld M., Hart R.G., Jansky P., Keltai M., Lakshmanan M., Lanas F.T., Leiter L.A., Munoz E.G.C., PATRICIO LOPEZ -JARAMILLO, Pogosova N., Probstfield J.L., Raubenheimer P.J., Riddle M.C., Rydén L.E., Shaw J.E., Sheu W.H.H., Temelkova-Kurktschiev T.

Total cardiovascular or fatal events in people with type 2 diabetes and cardiovascular risk factors treated with dulaglutide in the REWIND trail: a post hoc analysis

Abstract: Background: The Researching cardiovascular Events with a Weekly INcretin in Diabetes (REWIND) double

Palabras claves:

Cardiovascular disease, Glucagon like peptide-1 receptor agonists, Type 2 Diabetes

Atisso C.M., Basile J.N., Colhoun H.M., Conget I., Cushman W.C., Dagenais G.R., Dyal L., Gerstein H.C., Hall S., Keltai M., Lakshmanan M., Lanas F.T., Leiter L.A., Munoz E.G.C., Pais P., PATRICIO LOPEZ -JARAMILLO, Pirags V., Pogosova N., Probstfield J.L., Raubenheimer P.J., Riddle M.C., Rydén L.E., Shaw J.E., Sheu W.H.H., Temelkova-Kurktschiev T.